Virpax Pharmaceuticals VRPX
$ 0.62
-0.16%
Quarterly report 2024-Q3
added 11-14-2024
Virpax Pharmaceuticals Financial Statements 2011-2024 | VRPX
Annual Financial Statements Virpax Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
4.54 M | 1.02 M | 14.2 M | - | - | - | - | - | - | - | - | - | - |
Shares |
1.17 M | 1.17 M | 6.68 M | - | - | - | - | - | - | - | - | - | - |
Historical Prices |
3.88 | 0.87 | 2.13 | - | - | - | - | - | - | - | - | - | - |
Net Income |
-15.2 M | -21.7 M | -12.1 M | -4.34 M | -3.31 M | -2.64 M | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-15.7 M | -21.8 M | -12 M | -4.2 M | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | 92.8 K | 148 K | - | - | - | - | - | - | - | - | - |
EBITDA |
-15.7 M | -21.8 M | -12 M | - | -3.18 M | -2.63 M | - | - | - | - | - | - | - |
Operating Expenses |
15.7 M | 21.8 M | 12 M | 4.2 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
10.6 M | 11.1 M | 915 K | 2.9 M | 2.56 M | 1.48 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Virpax Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
4.66 M | 1.98 M | 1.17 M | 1.17 M | 1.17 M | 1.17 M | 1.17 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 6.01 M | 4.96 M | 3.95 M | 3.15 M | 3.14 M | 3.09 M | 3.04 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-2.01 M | -3.45 M | -3.22 M | - | -5.99 M | -3.11 M | -1.52 M | - | -7.64 M | -5.88 M | -5.14 M | - | -3.22 M | -2.34 M | -2.38 M | - | -1.71 M | -1.27 M | -656 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-1.92 M | -3.46 M | -3.3 M | - | -6.12 M | -3.24 M | -1.65 M | - | -7.72 M | -5.9 M | -5.12 M | - | -3.25 M | -2.31 M | -2.35 M | - | -1.66 M | -1.23 M | -616 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-82.1 K | - | - | - | 121 K | - | - | - | - | - | - | - | 28.9 K | 34 K | 30.7 K | - | 45.7 K | 43.3 K | 40.6 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-1.92 M | -3.46 M | -3.3 M | - | -6.12 M | -3.24 M | -1.65 M | - | -7.72 M | -5.9 M | -5.12 M | - | -3.25 M | -2.31 M | -2.35 M | - | -1.66 M | -1.23 M | -616 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
1.92 M | 3.46 M | 3.3 M | - | 6.12 M | 3.24 M | 1.65 M | - | 7.72 M | 5.9 M | 5.12 M | - | 3.25 M | 2.31 M | 2.35 M | - | 1.66 M | 1.23 M | 616 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
781 K | 1.5 M | 1.69 M | - | 4.62 M | 1.95 M | 415 K | - | 4.91 M | 208 K | 175 K | - | 122 K | 303 K | 370 K | - | 435 K | 572 K | 449 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency